{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:53:07Z","timestamp":1777632787389,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004482","name":"Kuwait University","doi-asserted-by":"publisher","award":["MI 01\/18"],"award-info":[{"award-number":["MI 01\/18"]}],"id":[{"id":"10.13039\/501100004482","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jiph.2021.08.020","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T11:48:36Z","timestamp":1629287316000},"page":"1612-1613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["First report of extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) infection in Kuwait"],"prefix":"10.1016","volume":"14","author":[{"given":"Eiman","family":"Mokaddas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3492-4781","authenticated-orcid":false,"given":"Suhail","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanaa S.","family":"Eldeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husam","family":"Zaglul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noura M.","family":"Al-Mutairi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahad","family":"Al-Otaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2021.08.020_bib0005","series-title":"Global tuberculosis report 2020","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.jiph.2021.08.020_bib0010","series-title":"Global tuberculosis report 2019. WHO\/CDS\/\/TB\/2019.15","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.jiph.2021.08.020_bib0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jiph.2013.09.001","article-title":"Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis","volume":"7","author":"Ahmad","year":"2014","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jiph.2021.08.020_bib0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-2600(17)30079-6","article-title":"The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis","volume":"5","author":"Dheda","year":"2017","journal-title":"Lancet Resp Med"},{"key":"10.1016\/j.jiph.2021.08.020_bib0025","first-page":"319","article-title":"Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996\u20132005","volume":"12","author":"Mokaddas","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jiph.2021.08.020_bib0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/14787210.2018.1519393","article-title":"Epidemiology of tuberculosis and multidrug-resistant tuberculosis in the Middle East Region","volume":"16","author":"Ahmad","year":"2018","journal-title":"Expert Rev Anti Infective Ther"},{"key":"10.1016\/j.jiph.2021.08.020_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153563","article-title":"Discordance across phenotypic and molecular methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a low TB incidence country","volume":"11","author":"Ahmad","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jiph.2021.08.020_bib0040","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1128\/JCM.03412-14","article-title":"Discordance between Xpert MTB\/RIF assay and Bactec MGIT 960 culture system for detection of rifampin-resistant Mycobacterium tuberculosis isolates in a country with a low tuberculosis (TB) incidence","volume":"53","author":"Mokaddas","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiph.2021.08.020_bib0045","doi-asserted-by":"crossref","first-page":"7765","DOI":"10.1038\/s41598-021-87516-0","article-title":"Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait","volume":"11","author":"Al-Mutairi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiph.2021.08.020_bib0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tube.2006.05.004","article-title":"Frequency of embB codon 306 mutations in ethambutol-sensitive and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait","volume":"87","author":"Ahmad","year":"2007","journal-title":"Tuberculosis (Edinburgh)"},{"key":"10.1016\/j.jiph.2021.08.020_bib0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12879-018-3638-z","article-title":"Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis","volume":"19","author":"Al-Mutairi","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2021.08.020_bib0060","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jmoldx.2020.06.010","article-title":"Specific gyrA gene mutations correlate with high prevalence of discordant levofloxacin resistance in Mycobacterium tuberculosis isolates from Beijing, China","volume":"22","author":"Huo","year":"2020","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jiph.2021.08.020_bib0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40001-019-0397-2","article-title":"Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB","volume":"24","author":"Al-Mutairi","year":"2019","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jiph.2021.08.020_bib0070","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1128\/JCM.00152-17","article-title":"Increased tuberculosis patient mortality associated with Mycobacterium tuberculosis mutations conferring resistance to second-line antituberculous drugs","volume":"55","author":"Georghiou","year":"2017","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034121002392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034121002392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:10:21Z","timestamp":1761750621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034121002392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1876034121002392"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2021.08.020","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First report of extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) infection in Kuwait","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2021.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}